USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Lipid Specialties Inc
Address:
21 Tioga Way
Marblehead, MA 01945
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
4
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $317,000.00 7

Award List:

PERFLUOROCHEMICALS, DESPITE INSOLUBILITY IN WATER, HAVE SHOWN PROMISE AS OXYGEN CARRIERS IN ACELLULAR BLOOD SUBSTITUTES.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Jeffrey l. garwin , PRINCIPAL INVESTIGATOR
Abstract:
Perfluorochemicals, despite insolubility in water, have shown promise as oxygen carriers in acellular blood substitutes. the surfactant used for perfluorochemical emulsions is mildly toxic, and fluosol-da 20% emulsions (the most extensively tested) are stable only when frozen. our research objective… More

STUDIES IN THE MEDICAL LITERATURE SINCE THE 1970S HAVE STRONGLY SUGGESTED THAT EICOSAPENTAENOIC ACID (EPA) IS A SIGNIFICANT MODULATOR OF THROMBOXANE AND PROSTAGLANDIN ACTIVITY, PRIMARILY IN ITS ROLE AS A PRECURSOR OF THE 3 CLASS OF THROMBOXANES AND

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$33,000.00
Agency:
HHS
Principal Investigator:
Dr barry sears , PRINCIPAL INVESTIGATOR
Abstract:
Studies in the medical literature since the 1970s have strongly suggested that eicosapentaenoic acid (epa) is a significant modulator of thromboxane and prostaglandin activity, primarily in its role as a precursor of the 3 class of thromboxanes and prostaglandins. a recent 20-year epidemiological… More

THE PRIMARY TREATMENT FOR GALLSTONES IS SURGICAL REMOVAL.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$34,000.00
Agency:
HHS
Principal Investigator:
Dr barry sears , PRINCIPAL INVESTIGATOR
Abstract:
The primary treatment for gallstones is surgical removal. with a 1% mortality rate and substantial hospitalization costs, a search for less expensive and safer treatments for gallstone elimination is warranted. it has been shown that gallstones consist primarily of cholesterol and that their… More

THE PREPARATION OF PANCREATIC TISSUE EXTRACTS REQUIRES THE REMOVAL OF FATS-PRIMARILY TRIGLYCERIDES-FROM CRUDE TISSUE.

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Dr barry sears , PRINCIPAL INVESTIGATOR
Abstract:
The preparation of pancreatic tissue extracts requires the removal of fats-primarily triglycerides-from crude tissue. such extracted pancreatic tissue is of paramount importance in treating cystic fibrosis patients who suffer from pancreatic insufficiency. in the past, a variety of organicsolvents… More

NEW THERAPEUTIC AGENTS TO REDUCE TRIGLYCERIDE LEVELS

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Barry sears
Abstract:
High triglyceride levels have been shown to be a risk factor in cardiovascular disease. the high-dose dietary intake of marine oils containing an essential fatty acid, eicosapentaenoic acid (epa), has been shown to be very effective in reducing triglyceride levels in both type v hyperlipidemics and… More

DEVELOPMENT OF NEW ANTI-PLATELET AGGREGATING AGENTS

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Barry sears
Abstract:
Platelet aggregation plays a major role in cardiovascular disease. much of the present pharmaceutical research is focused on inhibitors of the formation of thromboxane a2, a prostaglandin derived from arachidonic acid. the dietary intake of an essential fatty acid, eicosapentaenoic acid (epa), has… More

IMPROVED INFANT NUTRITIONAL FORMULATIONS

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
It has been shown that long chain polyunsaturated essential fatty acids such as gamma linolenic acid (gla), eicosapentaenoic acid (epa), and docosahexaenoic acid (dha) are present in very high concentrations in human breast milk. in developing new and improved infant formulas, therenow appears to be… More